Publicaties 2015

• Joerger, van Schaik, Becker, Hayoz, Pollak, Cathomas, Winterhalder, Gillessen, Rothermundt. Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09). Prostate Cancer Prostatic Dis. 2015 Jun;18(2):167-72.
• de Keyser, Becker, Hofman, Lous, Uitterlinden, Visser, Stricker BH. The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels. Pharmacogenet Genomics. 2015 Mar;25(3):134-42.
• Pereboom, Becker, Amenchar, Verweij, van der Hoeven, Mulder. Stability assessment of repackaged bevacizumab for intravitreal administration. Int J Pharm Compd. 2015 Jan-Feb;19(1):70-2.
• Vermeer, Spierings, Mantel-Teeuwisse, Straus, Giezen, Leufkens, Egberts, De Bruin. Traceability of biologicals: present challenges in pharmacovigilance. Expert Opin Drug Saf. 2015 Jan;14(1):63-72.